BeStock  
Markets › Compare › CRSP vs DFTX

CRSP vs DFTX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
CRSP · CRISPR Therapeutics$39.10 ▲ 0.44%
DFTX · Definium Therapeutics$28.34 ▼ 3.87%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

56150244338433Nov 24, '25May 26, '26Nov 20, '26
  • CRSP -23.7%
  • DFTX +141.2%

Head to head

MetricCRSPDFTX
Price$39.10$28.34
Change today▲ 0.44%▼ 3.87%
Market cap$3.79B$3.88B
Return, 3 months-31.5%-34.5%
Return, year to date-25.4%+111.7%
Return, 1 year-22.2%+165.4%
P/E (TTM)––
P/B2.34.0
P/E percentile vs own 5y53rd9th
Dividend yield––
Revenue growth (YoY, latest qtr)+1,325.1%–
Net profit growth (YoY)-4.7%+24.2%
Gross margin-676.9%–
Operating margin-2,221.7%–
Net margin-1,955.7%–
Return on equity-25.6%-61.4%
Analyst target vs. price+89.9%+162.2%
Analyst buy share67%100%
RSI (14)2834
30-day volatility56.0%69.1%
Max drawdown, 1 year-37.1%-41.5%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • DFTX is the largest of the group by market value.
  • DFTX has returned the most over the past year.
  • CRSP has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top